Journals / Turkish Journal of Pediatrics / 2017 / Cilt: 59 - Sayı: 2

Rational drug use for acute bronchiolitis in emergency care

Pages
155–161
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally, this option seems to be more effective toreduce length of hospital stay.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Despite the large variety of inhaled treatment options of acute bronchiolitis,there is no generally agreed treatment regime.
📊
Key Findings & Data:Themean age of the 378 infants included in the study was 7.63 ± 4.6 months,and 54.8% (207) were boys.
💡
Conclusion & Impact:Additionally, this option seems to be more effective toreduce length of hospital stay.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Despite the large variety of inhaled treatment options of acute bronchiolitis,there is no generally agreed treatment regime. This study aimed to determinethe most appropriate treatment option. This was a double-blind randomizedprospective clinical trial and has been performed in emergency department. Themean age of the 378 infants included in the study was 7.63 ± 4.6 months,and 54.8% (207) were boys. Patients were randomized by using the lotterymethod for simple random sample into 5 different treatment options; 3%hypertonic saline, nebulized adrenaline, nebulized adrenaline mixed with 3%hypertonic saline, nebulized salbutamol, and as control group; normal saline(0.9% NaCl). From the first treatment time until discharge time; treatmentdurations, adverse events and readmission rates within the first fifteendays were recorded for each patient. Nebulized adrenaline mixed with 3%hypertonic saline, as compared with other options, were associated with asignificantly higher discharge rate at 4th hours (p<0.001) and shorter lengthof hospital stay (p=0.039). However, there was no significant differencebetween options with regard to adverse events, discharge rates at 24thhours, and readmission rates within the first fifteen days. The superiority ofdischarge rates at 4 hours of nebulized adrenaline mixed with 3% hypertonicsaline, was evaluated as ‘better acute response’ and can be helpful to reducehospitalization needs. Additionally, this option seems to be more effective toreduce length of hospital stay.

🔖

Cite This Article

UYSALOL, M., HAŞLAK, F., ÖZÜNAL, Z. G., VEHİD, H., UZEL, N. (2017). Rational drug use for acute bronchiolitis in emergency care. Turkish Journal of Pediatrics, Cilt: 59 - Sayı: 2, 155–161. https://ajindex.com/articles/412197

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Simsek-Kiper PO, Kiper N, Hascelik G, et al. Emergency room management of acute bronchiolitis: a randomized trial of nebulized epinephrine. Turk J Pediatr 2011; 53: 651-660
  2. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143: 127-132
  3. Simoes EF. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 2003; 143: 118-126
  4. Hall BC, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis 2001; 33: 792-796
  5. Yorita KL, Holman RC, Sejvar JJ, Steiner CA, Schonberger LB. Infectious disease hospitalizations among infants in the United States. Pediatrics 2008; 121: 244-252
  6. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014; 134: 1474- 1502
  7. Seiden JA, Scarfone RJ. Bronchiolitis: An evidencebased approach to management. Clin Pediatr Emerg Med 2009; 10: 75-81
  8. Kuyucu S, Unal S, Kuyucu N, Yilgor E. Additive effects of dexamethasone in nebulized salbutamol or L-epinephrine treated infants with acute bronchiolitis. Pediatr Int 2004; 46: 539-544
  9. Wright RB, Pomerantz WJ, Luria JW. New approaches to respiratory infections in children: bronchiolitis and croup. Emerg Med Clin North Am 2002; 20: 93-114
  10. Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003; 349: 27-35
  11. Mull CC, Scarfone RJ, Ferri LR, et al. A randomized trial of nebulized epinephrine vs albuterol in the emergency department treatment of bronchiolitis. Arch Pediatr Adolesc Med 2004; 158: 113-118
  12. Scarfone R. Controversies in the treatment of bronchiolitis. Curr Opin Pediatr 2005; 17:62-66
  13. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006; 368: 312–322
  14. Bush A, Thomson AH. Acute bronchiolitis. BMJ 2007; 335: 1037–1041
  15. Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oxymetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis 1992; 145: 106-109
  16. Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelber A. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years’ experience. Isr Med Assoc J 2006; 8: 169-173. 17.